{"gene":"POLR1E","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":1996,"finding":"PAF53 (POLR1E) interacts with the upstream binding factor UBF in vitro, as demonstrated by Far-Western blotting and GST pull-down assays. Anti-PAF53 antibody blocks specific transcription from the mouse rRNA promoter but not random (non-specific) transcription, establishing PAF53 as required for accurate initiation of Pol I transcription. PAF53 accumulates in the nucleolus of growing cells.","method":"GST pull-down, Far-Western blotting, antibody inhibition of in vitro transcription, immunofluorescence","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — multiple orthogonal biochemical methods (pull-down, Far-Western, in vitro transcription inhibition) in a single focused study establishing direct protein–protein interaction and functional requirement","pmids":["8641287"],"is_preprint":false},{"year":1997,"finding":"PAF53 is a constitutive, stoichiometric subunit of RNA Pol I rather than a loosely associated regulatory factor. The molar ratio of PAF53 to the second-largest subunit RPA116 is constant across crude and highly purified Pol I fractions and does not change between exponentially growing and growth-arrested cells. Under all conditions of repressed rDNA transcription tested (serum starvation, actinomycin treatment, mitosis), PAF53 remains attached to the Pol I complex.","method":"Immunoblot analysis, immunoprecipitation, immunofluorescence, comparison of purified Pol I fractions","journal":"Chromosoma","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (immunoblot, Co-IP, immunofluorescence) in a single focused study with rigorous quantitative analysis","pmids":["9254723"],"is_preprint":false},{"year":2000,"finding":"In mouse oocytes, the RNA Pol I subunits RPA116 and PAF53/RPA53 co-localize with UBF within discrete nucleolar foci regardless of transcription status. After germinal vesicle breakdown, the RNA Pol I complex (including PAF53) disassembles from chromosomes in a step-wise manner during meiosis, whereas UBF remains chromosome-associated until late prometaphase I. Neither RNA Pol I nor PAF53 is detectable at metaphase II.","method":"High-resolution immunofluorescence, confocal microscopy, phosphatase inhibitor (okadaic acid) treatment","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — localization by immunofluorescence across multiple conditions with functional correlation, single lab","pmids":["10882521"],"is_preprint":false},{"year":2002,"finding":"Overexpression of the yeast HMG-box protein Hmo1 suppresses the growth defect of rpa49-Δ mutants (lacking the PAF53 yeast orthologue) and strongly increases de novo rRNA synthesis. Double mutants rpa49-Δ hmo1-Δ are lethal, and this lethality is bypassed when RNA Pol II synthesizes rRNA, placing Rpa49/PAF53 and Hmo1 in the same essential Pol I transcription pathway.","method":"Genetic epistasis, suppressor analysis, rRNA synthesis measurement, double-mutant lethality rescue","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with multiple alleles and functional rescue, replicated across multiple mutant combinations","pmids":["12374750"],"is_preprint":false},{"year":2004,"finding":"PAF53 interacts physically with PAF49 through PAF49's N-terminal segment, as demonstrated by co-immunoprecipitation. Both PAF49 and PAF53 co-purify with the transcriptionally active fraction of Pol I. Anti-PAF49 antibody severely impairs specific in vitro transcription from the mouse rRNA promoter, which is rescued by recombinant PAF49.","method":"Co-immunoprecipitation, co-purification, in vitro transcription assay with antibody inhibition and rescue","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — reciprocal Co-IP plus in vitro transcription assay with antibody inhibition and recombinant protein rescue, single lab with multiple orthogonal methods","pmids":["15226435"],"is_preprint":false},{"year":2006,"finding":"Acetylation of UBF (occurring in S-phase) augments the interaction between UBF and PAF53 and promotes Pol I recruitment to rDNA. In cells overexpressing HDAC1, UBF is hypoacetylated, co-immunoprecipitation of UBF with anti-PAF53 antibody is abolished, and Pol I association with rDNA and pre-rRNA synthesis are reduced.","method":"Co-immunoprecipitation, inducible HDAC1 overexpression, ChIP, in vitro pull-down","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP, ChIP and functional transcription data in a single focused study with multiple orthogonal methods","pmids":["16582105"],"is_preprint":false},{"year":2007,"finding":"The yeast Rpa49 (PAF53 orthologue) and Rpa34 subunits form a heterodimer; Rpa34 binds the N-terminal region of Rpa49 in a two-hybrid assay, and Rpa34 is lost from Pol I in an rpa49 mutant lacking this binding domain. The Rpa49–Rpa34 dimer has a dual role: it partially facilitates recruitment of the initiation factor Rrn3 to the rDNA promoter and is required for release of Rrn3 from the elongating polymerase.","method":"Two-hybrid assay, co-immunoprecipitation, ChIP, genetic mutant analysis, mycophenolate treatment","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple genetic alleles, two-hybrid, Co-IP, and ChIP across two orthologues in a single rigorous study","pmids":["18086878"],"is_preprint":false},{"year":2010,"finding":"The acetyltransferase hALP acetylates UBF and promotes the association of UBF with PAF53, as well as facilitating nuclear translocation of PAF53 from cytoplasm to nucleus. GST pull-down and co-immunoprecipitation showed that hALP binds UBF in vitro and in vivo. HAT-inactive hALP fails to promote these effects.","method":"Co-immunoprecipitation, GST pull-down, immunofluorescence (nuclear translocation), HAT-mutant analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — Co-IP, pull-down, and functional mutant analysis in a single lab; HAT-dead mutant provides mechanistic support","pmids":["21177859"],"is_preprint":false},{"year":2011,"finding":"Deletion of RPA49 (PAF53 orthologue) in S. cerevisiae leads to disappearance of nucleolar structure and a fourfold decrease in Pol I loading rate per rDNA gene, as assessed by Miller spread analysis. Human and S. pombe orthologues of Rpa49 functionally complement the S. cerevisiae rpa49-Δ growth defect (heterospecific complementation), demonstrating functional conservation. Reducing rDNA copy number from 190 to 25 restores nucleolar assembly in rpa49-Δ cells.","method":"Genetic deletion, heterospecific complementation, Miller spread electron microscopy, quantitative statistical analysis of polymerase loading","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic deletion with multiple readouts, quantitative electron microscopy (Miller spreads), cross-species functional complementation","pmids":["21263028"],"is_preprint":false},{"year":2013,"finding":"SIRT7 deacetylates PAF53 at lysine 373, and CBP acetylates PAF53 at the same residue. Hypoacetylation of PAF53 (by SIRT7) correlates with increased Pol I occupancy on rDNA and transcription activation, while hyperacetylation (upon SIRT7 release from nucleoli under stress) correlates with decreased Pol I transcription. SIRT7 is retained in nucleoli through binding to nascent pre-rRNA; stress conditions release SIRT7 from nucleoli, leading to PAF53 hyperacetylation.","method":"In vitro deacetylation assay, site-directed mutagenesis (K373), ChIP, co-immunoprecipitation, RNA-binding assay, stress-condition experiments","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vitro enzymatic assay, site-specific mutagenesis, ChIP, and Co-IP across multiple conditions, single rigorous study with multiple orthogonal methods","pmids":["24207024"],"is_preprint":false},{"year":2012,"finding":"PAF53 (and the broader Pol I elongation machinery including Rpa34/Rpa49 in yeast) is characterized as a built-in elongation factor essential for the extremely high rate of rRNA production per gene. The PAF53/CAST heterodimer in humans is the functional counterpart of Rpa34/Rpa49 in yeast for rRNA elongation.","method":"Review/synthesis of genetic and biochemical data (not a primary experimental paper, but synthesizes established results)","journal":"Genetics research international","confidence":"Low","confidence_rationale":"Tier 4 / Weak — review article synthesizing prior findings, no new primary experiments reported","pmids":["22567380"],"is_preprint":false},{"year":2012,"finding":"In mammalian PAF49 and PAF53, the dimerization interface maps to amino acids 41–86 of PAF49 (sufficient for heterodimerization), consistent with homologous regions in yeast A34.5. Substitution of amino acids 52–98 of yeast A34.5 with amino acids 41–86 of mammalian PAF49 produces a chimeric protein that can heterodimerize with mouse PAF53, demonstrating structural/functional conservation of the dimerization domain.","method":"Deletion and substitution mutagenesis, co-immunoprecipitation, in silico structural analysis","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 / Moderate — systematic deletion/substitution mutagenesis with Co-IP validation and chimeric protein rescue, single lab","pmids":["22849406"],"is_preprint":false},{"year":2014,"finding":"The PAF49/PAF53 heterodimer interacts physically with the initiation factor Rrn3 (TIF-IA). The acetylation state of PAF49 regulates association of the heterodimer with Pol I: hypoacetylated heterodimer binds Pol I with greater affinity than acetylated heterodimer. Acetylation of PAF49 does not affect PAF49–PAF53 heterodimerization itself.","method":"Co-immunoprecipitation, acetylation analysis, affinity binding assays","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — Co-IP and binding assays with acetylation state manipulation, single lab, multiple readouts","pmids":["25225125"],"is_preprint":false},{"year":2016,"finding":"NAT10 autoacetylation at K426 is required for its ability to acetylate UBF, which in turn recruits PAF53 and RNA Pol I to rDNA. The K426R mutant of NAT10 still binds UBF but cannot acetylate it and fails to recruit PAF53 or Pol I to rDNA, resulting in inhibition of pre-rRNA transcription.","method":"In vitro autoacetylation assay, site-directed mutagenesis (K426R), co-immunoprecipitation, ChIP, pre-rRNA measurement","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro assay, mutagenesis, ChIP, and Co-IP in a single study; establishes PAF53 recruitment downstream of UBF acetylation","pmids":["27993683"],"is_preprint":false},{"year":2019,"finding":"PAF53 (mammalian orthologue of yeast Rpa49) is essential for rDNA transcription and mitotic cell growth in mammalian cells, as demonstrated by auxin-inducible degron depletion. All three PAF53 domains are required for function: the C-terminal tandem-winged helix (DNA-binding), the heterodimerization domain, and the linker domain. The linker contains a helix-turn-helix (HTH) motif that constitutes a second DNA-binding domain and is essential for function in both yeast and mammalian orthologues.","method":"CRISPR/Cas9 + auxin-inducible degron system, domain-deletion mutagenesis, rDNA transcription assays, cell growth assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional depletion with auxin degron plus systematic domain mutagenesis in mammalian cells with multiple functional readouts; conserved HTH domain validated in both yeast and mammalian orthologues","pmids":["31727736"],"is_preprint":false},{"year":2019,"finding":"In yeast, extragenic suppressors of rpa49-Δ growth defect map to the jaw-lobe module of Pol I (interface between lobe of Rpa135 and jaw of Rpa190/Rpa12), and the suppressor allele Rpa135-F301S restores normal rRNA synthesis and increases Pol I density on rDNA in the absence of Rpa49. In vitro tailed-template assays show Pol I bearing Rpa135-F301S is hyperactive, indicating Rpa49 (PAF53 orthologue) normally acts through this jaw-lobe interface to stimulate Pol I elongation activity.","method":"Genetic suppressor screen, biochemical rRNA synthesis analysis, in vitro tailed-template transcription assay, ChIP (Pol I density)","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — genetic suppressor analysis combined with in vitro transcription assay and ChIP; establishes mechanistic connection between Rpa49/PAF53 and specific Pol I structural domains","pmids":["31136569"],"is_preprint":false},{"year":2020,"finding":"Pol I mutants lacking the heterodimeric subunit Rpa34.5/Rpa49 (PAF49/PAF53 orthologue) show reduced processivity on naked DNA templates and even further reduced processivity in the presence of a nucleosomal barrier. Purified wild-type Pol I and Pol III (but not Pol II) can transcribe nucleosomal templates; the lobe-binding subunits Rpa34.5/Rpa49 facilitate passage through nucleosomes, suggesting a role for the PAF49/PAF53 heterodimer in chromatin transcription.","method":"In vitro transcription assays with purified WT and mutant Pol I on naked DNA and nucleosomal templates; comparison with Pol II and Pol III","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with purified polymerases and defined templates including nucleosomal substrates; direct comparison of WT vs. subunit-deletion mutants","pmids":["32060094"],"is_preprint":false},{"year":2016,"finding":"PAF53 is essential for mammalian cell survival. CRISPR/Cas9-mediated knockout of PAF53 in human 293 cells was only achieved when cells were simultaneously rescued with ectopic FLAG-tagged mouse PAF53. In the absence of ectopic expression, cells employed alternative survival mechanisms (recombination, alternative reading frames) to maintain PAF53 expression, and no clone lacking all PAF53 expression was obtained.","method":"CRISPR/Cas9 gene editing, DNA sequencing of modified loci, Western blot","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic essentiality demonstrated by inability to achieve full knockout without rescue, single lab","pmids":["28042089"],"is_preprint":false},{"year":2023,"finding":"PAF49 is essential for rDNA transcription and cell division in mammalian cells. Auxin-induced degradation of PAF49 leads to degradation of its binding partner PAF53 (but not vice versa), demonstrating a co-dependent stability relationship. PAF49 depletion induces nucleolar stress and p53 accumulation. The dimerization domain of PAF49 and an 'arm' domain that interacts with PolR1B are both required for rDNA transcription. Disruption of the PAF49–PolR1B interaction inhibits Pol I transcription and causes cancer cell death while arresting normal cells.","method":"Auxin-inducible degron system, domain deletion mutagenesis, co-immunoprecipitation, rDNA transcription assays, cell viability assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional depletion, domain mutagenesis, Co-IP, and functional transcription assays with cancer vs. normal cell comparison; establishes PAF53 stability depends on PAF49 but not the reverse","pmids":["37356716"],"is_preprint":false},{"year":2022,"finding":"In the yeast system, the N-terminal domains of the Rpa34.5/Rpa49 heterodimer (PAF49/PAF53 orthologue) facilitate backtracking and RNA cleavage activity of Pol I in defined in vitro systems. The heterodimer, together with the C-terminal domain of Rpa12.2, is required for transcription fidelity (faithful NTP incorporation), suggesting that efficient backtracking and RNA cleavage enabled by the heterodimer are prerequisites for proofreading.","method":"In vitro transcription assays with purified mutant Pol I variants, RNA cleavage assays, backtracking assays, fidelity assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — in vitro reconstitution with defined mutant polymerases and multiple functional assays (cleavage, backtracking, fidelity) in a single rigorous study","pmids":["35341765"],"is_preprint":false}],"current_model":"POLR1E (PAF53) is a constitutive, stoichiometric subunit of RNA polymerase I that forms an essential heterodimer with PAF49 (A34.5 orthologue); this heterodimer structurally resembles a TFIIF/TFIIE-like subcomplex and functions at multiple steps of the Pol I transcription cycle—facilitating initiation (through interaction with UBF and recruitment of Rrn3), promoting elongation and high polymerase loading rates on rDNA, enabling transcription through nucleosomal barriers, and supporting RNA cleavage and proofreading—while its activity is regulated by SIRT7-mediated deacetylation and CBP-mediated acetylation at lysine 373, with hypoacetylation promoting Pol I–rDNA association and hyperacetylation (triggered by stress-induced SIRT7 release from nucleoli) causing transcriptional repression."},"narrative":{"mechanistic_narrative":"POLR1E (PAF53) is a constitutive, stoichiometric subunit of RNA polymerase I that is essential for accurate rDNA transcription and cell proliferation [PMID:9254723, PMID:31727736, PMID:28042089]. It assembles into a heterodimer with PAF49 through PAF49's N-terminal segment (mammalian residues 41–86), an interface conserved with the yeast Rpa34.5/Rpa49 module [PMID:15226435, PMID:22849406], and this co-dependent pair is mutually stabilizing such that loss of PAF49 triggers PAF53 degradation, nucleolar stress, and p53 accumulation [PMID:37356716]. PAF53 functions across the Pol I transcription cycle: it interacts with the upstream binding factor UBF to enable accurate initiation [PMID:8641287], and its recruitment to rDNA is driven by acetylation of UBF [PMID:16582105]. Studies of the yeast orthologue establish that the heterodimer acts through the Pol I jaw-lobe interface to stimulate elongation and high polymerase loading rates, facilitates passage through nucleosomal barriers, and supports backtracking, RNA cleavage, and transcriptional fidelity [PMID:31136569, PMID:32060094, PMID:35341765]; the protein's C-terminal tandem-winged-helix DNA-binding domain, heterodimerization domain, and an HTH-containing linker that forms a second DNA-binding module are all required for function [PMID:31727736]. PAF53 activity is regulated by reversible acetylation at lysine 373, deacetylated by SIRT7 to promote Pol I–rDNA association and acetylated by CBP, with stress-induced release of SIRT7 from nucleoli causing hyperacetylation and transcriptional repression [PMID:24207024].","teleology":[{"year":1996,"claim":"Established PAF53 as a Pol I factor physically engaging UBF and functionally required for promoter-specific initiation, distinguishing it from general transcription activity.","evidence":"GST pull-down, Far-Western, and antibody inhibition of in vitro rRNA-promoter transcription, with nucleolar immunofluorescence","pmids":["8641287"],"confidence":"High","gaps":["Did not define which PAF53 domain contacts UBF","Role beyond initiation (elongation, termination) untested"]},{"year":1997,"claim":"Resolved whether PAF53 is a regulatory adaptor or a core enzyme component by showing a constant stoichiometric ratio to RPA116 across growth and repression states.","evidence":"Immunoblot, Co-IP, and immunofluorescence comparing purified Pol I fractions under serum starvation, actinomycin, and mitosis","pmids":["9254723"],"confidence":"High","gaps":["Constitutive association leaves open how transcriptional output is regulated","No structural placement within Pol I"]},{"year":2000,"claim":"Tracked the dynamics of PAF53/Pol I assembly during meiosis, showing stepwise Pol I disassembly distinct from UBF retention.","evidence":"High-resolution confocal immunofluorescence in mouse oocytes with okadaic acid treatment","pmids":["10882521"],"confidence":"Medium","gaps":["Descriptive localization without mechanism of disassembly","Phosphorylation triggers inferred from inhibitor only"]},{"year":2002,"claim":"Placed the PAF53 orthologue Rpa49 in a common essential Pol I pathway with the HMG-box protein Hmo1 through genetic epistasis.","evidence":"Suppressor analysis, double-mutant lethality, and rRNA synthesis in S. cerevisiae","pmids":["12374750"],"confidence":"High","gaps":["Did not define the biochemical step shared by Rpa49 and Hmo1","Mammalian relevance of Hmo1 link untested"]},{"year":2004,"claim":"Identified PAF49 as the direct heterodimer partner of PAF53 and confirmed both reside in the active Pol I fraction and are required for initiation.","evidence":"Reciprocal Co-IP, co-purification, and antibody inhibition/recombinant rescue of in vitro transcription","pmids":["15226435"],"confidence":"High","gaps":["Heterodimer interface not mapped","Functional role of dimer beyond initiation unresolved"]},{"year":2006,"claim":"Defined acetylation of UBF as a control point that strengthens the UBF–PAF53 interaction and drives Pol I recruitment to rDNA.","evidence":"Co-IP, ChIP, and inducible HDAC1 overexpression with pre-rRNA measurement","pmids":["16582105"],"confidence":"High","gaps":["Acetyltransferase responsible not identified here","Direct vs. indirect effect on PAF53 not separated"]},{"year":2007,"claim":"Defined the dual mechanistic role of the Rpa49/Rpa34 (PAF53/PAF49) heterodimer in recruiting Rrn3 and in releasing Rrn3 from elongating polymerase.","evidence":"Two-hybrid, Co-IP, ChIP, and genetic mutant analysis in yeast","pmids":["18086878"],"confidence":"High","gaps":["Mammalian conservation of Rrn3 handoff not directly shown here","Structural basis of Rrn3 release unknown"]},{"year":2010,"claim":"Identified hALP as an acetyltransferase that acetylates UBF, promotes UBF–PAF53 association, and drives PAF53 nuclear translocation.","evidence":"Co-IP, GST pull-down, immunofluorescence, and HAT-dead mutant analysis","pmids":["21177859"],"confidence":"Medium","gaps":["Single-lab finding without independent confirmation","Physiological context regulating PAF53 import unclear"]},{"year":2011,"claim":"Quantified the elongation contribution of the PAF53 orthologue, showing it is required for nucleolar structure and high polymerase loading, and that function is conserved across species.","evidence":"Genetic deletion, heterospecific complementation with human/S. pombe orthologues, and Miller-spread electron microscopy in yeast","pmids":["21263028"],"confidence":"High","gaps":["Molecular mechanism of loading-rate increase not resolved here","Link to specific Pol I structural elements pending"]},{"year":2012,"claim":"Mapped the heterodimerization interface to PAF49 residues 41–86 and demonstrated its conservation via a functional yeast chimera.","evidence":"Deletion/substitution mutagenesis, Co-IP, and chimeric-protein heterodimerization assays","pmids":["22849406"],"confidence":"Medium","gaps":["Crystal structure of the interface not determined","Consequences of interface disruption on transcription untested here"]},{"year":2013,"claim":"Established lysine 373 acetylation as a regulatory switch on PAF53 controlled by SIRT7 and CBP, linking stress signaling to Pol I activity.","evidence":"In vitro deacetylation, K373 site-directed mutagenesis, ChIP, Co-IP, RNA-binding, and stress-condition experiments","pmids":["24207024"],"confidence":"High","gaps":["How K373 acetylation alters PAF53 contacts mechanistically unresolved","Other PAF53 modification sites not surveyed"]},{"year":2014,"claim":"Showed the PAF49/PAF53 heterodimer contacts Rrn3 in mammals and that PAF49 acetylation tunes heterodimer affinity for Pol I without disrupting dimerization.","evidence":"Co-IP, acetylation analysis, and affinity binding assays","pmids":["25225125"],"confidence":"Medium","gaps":["Acetyltransferase/deacetylase for PAF49 not identified","In vivo significance of affinity change untested"]},{"year":2016,"claim":"Demonstrated PAF53 is essential for mammalian cell survival, as knockout could not be obtained without ectopic rescue.","evidence":"CRISPR/Cas9 editing with locus sequencing and Western blot in 293 cells","pmids":["28042089"],"confidence":"Medium","gaps":["Essentiality shown by inability to knock out, not by clean conditional depletion","Cause of lethality not dissected here"]},{"year":2016,"claim":"Positioned PAF53 recruitment downstream of NAT10-mediated UBF acetylation, adding another acetyltransferase to the recruitment cascade.","evidence":"In vitro autoacetylation, NAT10 K426R mutagenesis, Co-IP, ChIP, and pre-rRNA measurement","pmids":["27993683"],"confidence":"Medium","gaps":["Relationship between NAT10 and other UBF acetyltransferases (hALP) unresolved","Direct PAF53 contact with NAT10 not shown"]},{"year":2019,"claim":"Defined the domain architecture required for PAF53 function, including a second HTH DNA-binding module in the linker, using clean conditional depletion in mammalian cells.","evidence":"Auxin-inducible degron depletion plus systematic domain-deletion mutagenesis with rDNA transcription and growth assays","pmids":["31727736"],"confidence":"High","gaps":["Precise DNA target of the HTH module unknown","How the two DNA-binding domains coordinate on rDNA unresolved"]},{"year":2019,"claim":"Localized PAF53/Rpa49 elongation stimulation to the Pol I jaw-lobe interface through suppressor genetics and biochemistry.","evidence":"Suppressor screen, in vitro tailed-template transcription, and ChIP of Pol I density in yeast","pmids":["31136569"],"confidence":"High","gaps":["Structural snapshot of the active jaw-lobe conformation not captured","Mammalian conservation of this allosteric route untested"]},{"year":2020,"claim":"Showed the heterodimer enables Pol I processivity through nucleosomal barriers, extending its role to chromatin transcription.","evidence":"In vitro transcription with purified WT and subunit-deletion Pol I on naked and nucleosomal templates, compared with Pol II/III","pmids":["32060094"],"confidence":"High","gaps":["Mechanism of nucleosome destabilization by the heterodimer unresolved","In vivo chromatin templates not directly tested"]},{"year":2022,"claim":"Assigned a proofreading function to the heterodimer by showing its N-terminal domains drive backtracking and RNA cleavage required for fidelity.","evidence":"In vitro transcription, RNA cleavage, backtracking, and fidelity assays with purified mutant Pol I","pmids":["35341765"],"confidence":"High","gaps":["Contribution of mammalian PAF53 to fidelity not directly tested","Interplay with Rpa12.2 C-terminal domain only partly resolved"]},{"year":2023,"claim":"Established the co-dependent stability of the heterodimer (PAF49 loss degrades PAF53 but not vice versa) and identified the PAF49–PolR1B interaction as a druggable Pol I dependency in cancer cells.","evidence":"Auxin degron depletion, domain mutagenesis, Co-IP, and viability assays comparing cancer vs. normal cells","pmids":["37356716"],"confidence":"High","gaps":["Structural basis of the PAF49–PolR1B 'arm' interaction not defined","Selectivity window for cancer-cell killing not mechanistically explained"]},{"year":null,"claim":"How the multiple regulatory layers (K373 acetylation, UBF-acetylation-driven recruitment, jaw-lobe elongation control) are integrated in vivo, and whether mammalian PAF53 directly contributes to proofreading, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No integrated structural model of regulated PAF53 across the transcription cycle","Direct mammalian assays for backtracking/fidelity lacking","Disease association of POLR1E not established in the corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[14]},{"term_id":"GO:0140098","term_label":"catalytic activity, acting on RNA","supporting_discovery_ids":[16,19]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[1,4]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,6,12]}],"localization":[{"term_id":"GO:0005730","term_label":"nucleolus","supporting_discovery_ids":[0,1,8]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[7]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,4,14]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[16,19]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[9,18]}],"complexes":["RNA polymerase I","PAF53–PAF49 heterodimer"],"partners":["PAF49","UBF","RRN3","SIRT7","CBP","POLR1B","RPA116"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9GZS1","full_name":"DNA-directed RNA polymerase I subunit RPA49","aliases":["DNA-directed RNA polymerase I subunit E","RNA polymerase I-associated factor 1","RNA polymerase I-associated factor 53"],"length_aa":419,"mass_kda":47.3,"function":"Component of RNA polymerase I (Pol I), a DNA-dependent RNA polymerase which synthesizes ribosomal RNA precursors using the four ribonucleoside triphosphates as substrates (PubMed:24207024, PubMed:34671025, PubMed:34887565, PubMed:36271492). Appears to be involved in the formation of the initiation complex at the promoter by mediating the interaction between Pol I and UBTF/UBF (PubMed:24207024)","subcellular_location":"Nucleus, nucleolus","url":"https://www.uniprot.org/uniprotkb/Q9GZS1/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/POLR1E","classification":"Common Essential","n_dependent_lines":978,"n_total_lines":1208,"dependency_fraction":0.8096026490066225},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000137054","cell_line_id":"CID000844","localizations":[{"compartment":"nucleolus_fc_dfc","grade":3},{"compartment":"nuclear_punctae","grade":2}],"interactors":[{"gene":"POLR1B","stoichiometry":10.0},{"gene":"POLR1C","stoichiometry":10.0},{"gene":"POLR2K","stoichiometry":10.0},{"gene":"POLR2E","stoichiometry":10.0},{"gene":"POLR2F","stoichiometry":4.0},{"gene":"POLR2H","stoichiometry":4.0},{"gene":"NCL","stoichiometry":0.2},{"gene":"TWISTNB","stoichiometry":0.2},{"gene":"KPNA2","stoichiometry":0.2},{"gene":"KPNA1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000844","total_profiled":1310},"omim":[{"mim_id":"621031","title":"POLYMERASE I, RNA, SUBUNIT E; POLR1E","url":"https://www.omim.org/entry/621031"},{"mim_id":"600673","title":"UPSTREAM BINDING TRANSCRIPTION FACTOR (RNA POLYMERASE I); UBTF","url":"https://www.omim.org/entry/600673"},{"mim_id":"107325","title":"POLYMERASE I, RNA, SUBUNIT G; POLR1G","url":"https://www.omim.org/entry/107325"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nucleoplasm","reliability":"Supported"},{"location":"Nucleoli fibrillar center","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/POLR1E"},"hgnc":{"alias_symbol":["FLJ13390","PAF53","FLJ13970","RPA49"],"prev_symbol":["PRAF1"]},"alphafold":{"accession":"Q9GZS1","domains":[{"cath_id":"-","chopping":"9-113","consensus_level":"high","plddt":86.06,"start":9,"end":113},{"cath_id":"-","chopping":"209-406","consensus_level":"high","plddt":88.7839,"start":209,"end":406}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZS1","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZS1-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9GZS1-F1-predicted_aligned_error_v6.png","plddt_mean":82.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLR1E","jax_strain_url":"https://www.jax.org/strain/search?query=POLR1E"},"sequence":{"accession":"Q9GZS1","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9GZS1.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9GZS1/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9GZS1"}},"corpus_meta":[{"pmid":"24207024","id":"PMC_24207024","title":"Repression of RNA polymerase I upon stress is caused by inhibition of RNA-dependent deacetylation of PAF53 by SIRT7.","date":"2013","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/24207024","citation_count":167,"is_preprint":false},{"pmid":"12374750","id":"PMC_12374750","title":"Hmo1, an HMG-box protein, belongs to the yeast ribosomal DNA transcription system.","date":"2002","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/12374750","citation_count":96,"is_preprint":false},{"pmid":"25435428","id":"PMC_25435428","title":"Sirtuin 7 in cell proliferation, stress and disease: Rise of the Seventh Sirtuin!","date":"2014","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/25435428","citation_count":95,"is_preprint":false},{"pmid":"8641287","id":"PMC_8641287","title":"RNA polymerase I associated factor 53 binds to the nucleolar transcription factor UBF and functions in specific rDNA transcription.","date":"1996","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/8641287","citation_count":87,"is_preprint":false},{"pmid":"22403788","id":"PMC_22403788","title":"Mechanical loading induces the expression of a Pol I regulon at the onset of skeletal muscle hypertrophy.","date":"2012","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/22403788","citation_count":82,"is_preprint":false},{"pmid":"18086878","id":"PMC_18086878","title":"Two RNA polymerase I subunits control the binding and release of Rrn3 during transcription.","date":"2007","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/18086878","citation_count":71,"is_preprint":false},{"pmid":"10918607","id":"PMC_10918607","title":"RNA polymerase I transcription in confluent cells: Rb downregulates rDNA transcription during confluence-induced cell cycle arrest.","date":"2000","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/10918607","citation_count":70,"is_preprint":false},{"pmid":"21263028","id":"PMC_21263028","title":"RNA polymerase I-specific subunits promote polymerase clustering to enhance the rRNA gene transcription cycle.","date":"2011","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/21263028","citation_count":68,"is_preprint":false},{"pmid":"21177859","id":"PMC_21177859","title":"hALP, a novel transcriptional U three protein (t-UTP), activates RNA polymerase I transcription by binding and acetylating the upstream binding factor (UBF).","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21177859","citation_count":57,"is_preprint":false},{"pmid":"27993683","id":"PMC_27993683","title":"Autoacetylation of NAT10 is critical for its function in rRNA transcription activation.","date":"2016","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/27993683","citation_count":53,"is_preprint":false},{"pmid":"1409638","id":"PMC_1409638","title":"Characterization and mutagenesis of the gene encoding the A49 subunit of RNA polymerase A in Saccharomyces cerevisiae.","date":"1992","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/1409638","citation_count":50,"is_preprint":false},{"pmid":"10882521","id":"PMC_10882521","title":"Functional and molecular reorganization of the nucleolar apparatus in maturing mouse oocytes.","date":"2000","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/10882521","citation_count":50,"is_preprint":false},{"pmid":"9254723","id":"PMC_9254723","title":"Constitutive and strong association of PAF53 with RNA polymerase I.","date":"1997","source":"Chromosoma","url":"https://pubmed.ncbi.nlm.nih.gov/9254723","citation_count":46,"is_preprint":false},{"pmid":"28777933","id":"PMC_28777933","title":"Heterozygous De Novo UBTF Gain-of-Function Variant Is Associated with Neurodegeneration in Childhood.","date":"2017","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28777933","citation_count":42,"is_preprint":false},{"pmid":"24021628","id":"PMC_24021628","title":"Structure-function analysis of Hmo1 unveils an ancestral organization of HMG-Box factors involved in ribosomal DNA transcription from yeast to human.","date":"2013","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/24021628","citation_count":42,"is_preprint":false},{"pmid":"16582105","id":"PMC_16582105","title":"Acetylation of UBF changes during the cell cycle and regulates the interaction of UBF with RNA polymerase I.","date":"2006","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/16582105","citation_count":39,"is_preprint":false},{"pmid":"15226435","id":"PMC_15226435","title":"Multiple protein-protein interactions by RNA polymerase I-associated factor PAF49 and role of PAF49 in rRNA transcription.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15226435","citation_count":35,"is_preprint":false},{"pmid":"19061191","id":"PMC_19061191","title":"Identification of common traits in improved xylose-growing Saccharomyces cerevisiae for inverse metabolic engineering.","date":"2008","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19061191","citation_count":35,"is_preprint":false},{"pmid":"23470167","id":"PMC_23470167","title":"Tumour expression of bladder cancer-associated urinary proteins.","date":"2013","source":"BJU international","url":"https://pubmed.ncbi.nlm.nih.gov/23470167","citation_count":32,"is_preprint":false},{"pmid":"22567380","id":"PMC_22567380","title":"Regulation of ribosomal RNA production by RNA polymerase I: does elongation come first?","date":"2012","source":"Genetics research international","url":"https://pubmed.ncbi.nlm.nih.gov/22567380","citation_count":32,"is_preprint":false},{"pmid":"14627545","id":"PMC_14627545","title":"Regulation of ribosomal RNA synthesis during the final phases of porcine oocyte growth.","date":"2003","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/14627545","citation_count":26,"is_preprint":false},{"pmid":"31136569","id":"PMC_31136569","title":"Genetic analyses led to the discovery of a super-active mutant of the RNA polymerase I.","date":"2019","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31136569","citation_count":25,"is_preprint":false},{"pmid":"32060094","id":"PMC_32060094","title":"RNA polymerase I (Pol I) passage through nucleosomes depends on Pol I subunits binding its lobe structure.","date":"2020","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32060094","citation_count":23,"is_preprint":false},{"pmid":"36466608","id":"PMC_36466608","title":"Comprehensive analysis of dysregulated circular RNAs and construction of a ceRNA network involved in the pathology of Alzheimer's disease in a 5 × FAD mouse model.","date":"2022","source":"Frontiers in aging neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36466608","citation_count":21,"is_preprint":false},{"pmid":"14613906","id":"PMC_14613906","title":"Immunolocalization of upstream binding factor and pocket protein p130 during final stages of bovine oocyte growth.","date":"2003","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/14613906","citation_count":17,"is_preprint":false},{"pmid":"14585813","id":"PMC_14585813","title":"Expression of nucleolar-related proteins in porcine preimplantation embryos produced in vivo and in vitro.","date":"2003","source":"Biology of reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/14585813","citation_count":16,"is_preprint":false},{"pmid":"35341765","id":"PMC_35341765","title":"RNA polymerase I (Pol I) lobe-binding subunit Rpa12.2 promotes RNA cleavage and proofreading.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35341765","citation_count":15,"is_preprint":false},{"pmid":"32915199","id":"PMC_32915199","title":"Dynamics of the RNA polymerase I TFIIF/TFIIE-like subcomplex: a mini-review.","date":"2020","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/32915199","citation_count":13,"is_preprint":false},{"pmid":"25225125","id":"PMC_25225125","title":"Regulation of the association of the PAF53/PAF49 heterodimer with RNA polymerase I.","date":"2014","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/25225125","citation_count":12,"is_preprint":false},{"pmid":"31727736","id":"PMC_31727736","title":"Conditional depletion of the RNA polymerase I subunit PAF53 reveals that it is essential for mitosis and enables identification of functional domains.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31727736","citation_count":12,"is_preprint":false},{"pmid":"22849406","id":"PMC_22849406","title":"Characterization of the interactions of mammalian RNA polymerase I associated proteins PAF53 and PAF49.","date":"2012","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22849406","citation_count":12,"is_preprint":false},{"pmid":"12893961","id":"PMC_12893961","title":"The fission yeast RPA51 is a functional homolog of the budding yeast A49 subunit of RNA polymerase I and required for maximizing transcription of ribosomal DNA.","date":"2003","source":"Genes & genetic systems","url":"https://pubmed.ncbi.nlm.nih.gov/12893961","citation_count":12,"is_preprint":false},{"pmid":"18315500","id":"PMC_18315500","title":"Impairments in embryonic genome activation in rhesus monkey somatic cell nuclear transfer embryos.","date":"2008","source":"Cloning and stem cells","url":"https://pubmed.ncbi.nlm.nih.gov/18315500","citation_count":11,"is_preprint":false},{"pmid":"30269676","id":"PMC_30269676","title":"Identification of factors that promote biogenesis of tRNACGASer.","date":"2018","source":"RNA biology","url":"https://pubmed.ncbi.nlm.nih.gov/30269676","citation_count":10,"is_preprint":false},{"pmid":"37356716","id":"PMC_37356716","title":"PAF49: An RNA Polymerase I subunit essential for rDNA transcription and stabilization of PAF53.","date":"2023","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/37356716","citation_count":8,"is_preprint":false},{"pmid":"9234673","id":"PMC_9234673","title":"Sequence analysis of the 33 kb long region between ORC5 and SUI1 from the left arm of chromosome XIV from Saccharomyces cerevisiae.","date":"1997","source":"Yeast (Chichester, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9234673","citation_count":8,"is_preprint":false},{"pmid":"36201324","id":"PMC_36201324","title":"LP07 and LLC preclinical models of lung cancer induce divergent anabolic deficits and expression of pro-inflammatory effectors of muscle wasting.","date":"2022","source":"Journal of applied physiology (Bethesda, Md. : 1985)","url":"https://pubmed.ncbi.nlm.nih.gov/36201324","citation_count":7,"is_preprint":false},{"pmid":"30316990","id":"PMC_30316990","title":"Polymerase-1 pathway activation in acute multiple sclerosis relapse.","date":"2018","source":"Autoimmunity reviews","url":"https://pubmed.ncbi.nlm.nih.gov/30316990","citation_count":6,"is_preprint":false},{"pmid":"23534980","id":"PMC_23534980","title":"TNF-alpha and melphalan modulate a specific group of early expressed genes in a murine melanoma model.","date":"2013","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/23534980","citation_count":6,"is_preprint":false},{"pmid":"28042089","id":"PMC_28042089","title":"PAF53 is essential in mammalian cells: CRISPR/Cas9 fails to eliminate PAF53 expression.","date":"2016","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/28042089","citation_count":4,"is_preprint":false},{"pmid":"16187064","id":"PMC_16187064","title":"Re-localization of nuclear DNA helicase II during the growth period of bovine oocytes.","date":"2005","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/16187064","citation_count":4,"is_preprint":false},{"pmid":"33921963","id":"PMC_33921963","title":"The Mammalian and Yeast A49 and A34 Heterodimers: Homologous but Not the Same.","date":"2021","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/33921963","citation_count":3,"is_preprint":false},{"pmid":"41714438","id":"PMC_41714438","title":"Pharmacogenomics of antiepileptic drug mood stabilizer treatment response in bipolar disorder: A MoStGen Consortium study.","date":"2026","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/41714438","citation_count":1,"is_preprint":false},{"pmid":"23608169","id":"PMC_23608169","title":"Meeting report for Odd Pols 2012.","date":"2013","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/23608169","citation_count":0,"is_preprint":false},{"pmid":"41551691","id":"PMC_41551691","title":"Unfolding the enigma of familial Hodgkin lymphoma: Current insights.","date":"2026","source":"World journal of clinical cases","url":"https://pubmed.ncbi.nlm.nih.gov/41551691","citation_count":0,"is_preprint":false},{"pmid":"39858608","id":"PMC_39858608","title":"Evolutionary and Structural Insights into the RNA Polymerase I A34 Protein Family: A Focus on Intrinsic Disorder and Phase Separation.","date":"2025","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/39858608","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":24832,"output_tokens":5561,"usd":0.078955,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":14057,"output_tokens":5188,"usd":0.099992,"stage2_stop_reason":"end_turn"},"total_usd":0.178947,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"PAF53 (POLR1E) interacts with the upstream binding factor UBF in vitro, as demonstrated by Far-Western blotting and GST pull-down assays. Anti-PAF53 antibody blocks specific transcription from the mouse rRNA promoter but not random (non-specific) transcription, establishing PAF53 as required for accurate initiation of Pol I transcription. PAF53 accumulates in the nucleolus of growing cells.\",\n      \"method\": \"GST pull-down, Far-Western blotting, antibody inhibition of in vitro transcription, immunofluorescence\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — multiple orthogonal biochemical methods (pull-down, Far-Western, in vitro transcription inhibition) in a single focused study establishing direct protein–protein interaction and functional requirement\",\n      \"pmids\": [\"8641287\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"PAF53 is a constitutive, stoichiometric subunit of RNA Pol I rather than a loosely associated regulatory factor. The molar ratio of PAF53 to the second-largest subunit RPA116 is constant across crude and highly purified Pol I fractions and does not change between exponentially growing and growth-arrested cells. Under all conditions of repressed rDNA transcription tested (serum starvation, actinomycin treatment, mitosis), PAF53 remains attached to the Pol I complex.\",\n      \"method\": \"Immunoblot analysis, immunoprecipitation, immunofluorescence, comparison of purified Pol I fractions\",\n      \"journal\": \"Chromosoma\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (immunoblot, Co-IP, immunofluorescence) in a single focused study with rigorous quantitative analysis\",\n      \"pmids\": [\"9254723\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"In mouse oocytes, the RNA Pol I subunits RPA116 and PAF53/RPA53 co-localize with UBF within discrete nucleolar foci regardless of transcription status. After germinal vesicle breakdown, the RNA Pol I complex (including PAF53) disassembles from chromosomes in a step-wise manner during meiosis, whereas UBF remains chromosome-associated until late prometaphase I. Neither RNA Pol I nor PAF53 is detectable at metaphase II.\",\n      \"method\": \"High-resolution immunofluorescence, confocal microscopy, phosphatase inhibitor (okadaic acid) treatment\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — localization by immunofluorescence across multiple conditions with functional correlation, single lab\",\n      \"pmids\": [\"10882521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Overexpression of the yeast HMG-box protein Hmo1 suppresses the growth defect of rpa49-Δ mutants (lacking the PAF53 yeast orthologue) and strongly increases de novo rRNA synthesis. Double mutants rpa49-Δ hmo1-Δ are lethal, and this lethality is bypassed when RNA Pol II synthesizes rRNA, placing Rpa49/PAF53 and Hmo1 in the same essential Pol I transcription pathway.\",\n      \"method\": \"Genetic epistasis, suppressor analysis, rRNA synthesis measurement, double-mutant lethality rescue\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with multiple alleles and functional rescue, replicated across multiple mutant combinations\",\n      \"pmids\": [\"12374750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PAF53 interacts physically with PAF49 through PAF49's N-terminal segment, as demonstrated by co-immunoprecipitation. Both PAF49 and PAF53 co-purify with the transcriptionally active fraction of Pol I. Anti-PAF49 antibody severely impairs specific in vitro transcription from the mouse rRNA promoter, which is rescued by recombinant PAF49.\",\n      \"method\": \"Co-immunoprecipitation, co-purification, in vitro transcription assay with antibody inhibition and rescue\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — reciprocal Co-IP plus in vitro transcription assay with antibody inhibition and recombinant protein rescue, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"15226435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Acetylation of UBF (occurring in S-phase) augments the interaction between UBF and PAF53 and promotes Pol I recruitment to rDNA. In cells overexpressing HDAC1, UBF is hypoacetylated, co-immunoprecipitation of UBF with anti-PAF53 antibody is abolished, and Pol I association with rDNA and pre-rRNA synthesis are reduced.\",\n      \"method\": \"Co-immunoprecipitation, inducible HDAC1 overexpression, ChIP, in vitro pull-down\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP, ChIP and functional transcription data in a single focused study with multiple orthogonal methods\",\n      \"pmids\": [\"16582105\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The yeast Rpa49 (PAF53 orthologue) and Rpa34 subunits form a heterodimer; Rpa34 binds the N-terminal region of Rpa49 in a two-hybrid assay, and Rpa34 is lost from Pol I in an rpa49 mutant lacking this binding domain. The Rpa49–Rpa34 dimer has a dual role: it partially facilitates recruitment of the initiation factor Rrn3 to the rDNA promoter and is required for release of Rrn3 from the elongating polymerase.\",\n      \"method\": \"Two-hybrid assay, co-immunoprecipitation, ChIP, genetic mutant analysis, mycophenolate treatment\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple genetic alleles, two-hybrid, Co-IP, and ChIP across two orthologues in a single rigorous study\",\n      \"pmids\": [\"18086878\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The acetyltransferase hALP acetylates UBF and promotes the association of UBF with PAF53, as well as facilitating nuclear translocation of PAF53 from cytoplasm to nucleus. GST pull-down and co-immunoprecipitation showed that hALP binds UBF in vitro and in vivo. HAT-inactive hALP fails to promote these effects.\",\n      \"method\": \"Co-immunoprecipitation, GST pull-down, immunofluorescence (nuclear translocation), HAT-mutant analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — Co-IP, pull-down, and functional mutant analysis in a single lab; HAT-dead mutant provides mechanistic support\",\n      \"pmids\": [\"21177859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Deletion of RPA49 (PAF53 orthologue) in S. cerevisiae leads to disappearance of nucleolar structure and a fourfold decrease in Pol I loading rate per rDNA gene, as assessed by Miller spread analysis. Human and S. pombe orthologues of Rpa49 functionally complement the S. cerevisiae rpa49-Δ growth defect (heterospecific complementation), demonstrating functional conservation. Reducing rDNA copy number from 190 to 25 restores nucleolar assembly in rpa49-Δ cells.\",\n      \"method\": \"Genetic deletion, heterospecific complementation, Miller spread electron microscopy, quantitative statistical analysis of polymerase loading\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic deletion with multiple readouts, quantitative electron microscopy (Miller spreads), cross-species functional complementation\",\n      \"pmids\": [\"21263028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"SIRT7 deacetylates PAF53 at lysine 373, and CBP acetylates PAF53 at the same residue. Hypoacetylation of PAF53 (by SIRT7) correlates with increased Pol I occupancy on rDNA and transcription activation, while hyperacetylation (upon SIRT7 release from nucleoli under stress) correlates with decreased Pol I transcription. SIRT7 is retained in nucleoli through binding to nascent pre-rRNA; stress conditions release SIRT7 from nucleoli, leading to PAF53 hyperacetylation.\",\n      \"method\": \"In vitro deacetylation assay, site-directed mutagenesis (K373), ChIP, co-immunoprecipitation, RNA-binding assay, stress-condition experiments\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vitro enzymatic assay, site-specific mutagenesis, ChIP, and Co-IP across multiple conditions, single rigorous study with multiple orthogonal methods\",\n      \"pmids\": [\"24207024\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PAF53 (and the broader Pol I elongation machinery including Rpa34/Rpa49 in yeast) is characterized as a built-in elongation factor essential for the extremely high rate of rRNA production per gene. The PAF53/CAST heterodimer in humans is the functional counterpart of Rpa34/Rpa49 in yeast for rRNA elongation.\",\n      \"method\": \"Review/synthesis of genetic and biochemical data (not a primary experimental paper, but synthesizes established results)\",\n      \"journal\": \"Genetics research international\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 4 / Weak — review article synthesizing prior findings, no new primary experiments reported\",\n      \"pmids\": [\"22567380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"In mammalian PAF49 and PAF53, the dimerization interface maps to amino acids 41–86 of PAF49 (sufficient for heterodimerization), consistent with homologous regions in yeast A34.5. Substitution of amino acids 52–98 of yeast A34.5 with amino acids 41–86 of mammalian PAF49 produces a chimeric protein that can heterodimerize with mouse PAF53, demonstrating structural/functional conservation of the dimerization domain.\",\n      \"method\": \"Deletion and substitution mutagenesis, co-immunoprecipitation, in silico structural analysis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 / Moderate — systematic deletion/substitution mutagenesis with Co-IP validation and chimeric protein rescue, single lab\",\n      \"pmids\": [\"22849406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The PAF49/PAF53 heterodimer interacts physically with the initiation factor Rrn3 (TIF-IA). The acetylation state of PAF49 regulates association of the heterodimer with Pol I: hypoacetylated heterodimer binds Pol I with greater affinity than acetylated heterodimer. Acetylation of PAF49 does not affect PAF49–PAF53 heterodimerization itself.\",\n      \"method\": \"Co-immunoprecipitation, acetylation analysis, affinity binding assays\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — Co-IP and binding assays with acetylation state manipulation, single lab, multiple readouts\",\n      \"pmids\": [\"25225125\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"NAT10 autoacetylation at K426 is required for its ability to acetylate UBF, which in turn recruits PAF53 and RNA Pol I to rDNA. The K426R mutant of NAT10 still binds UBF but cannot acetylate it and fails to recruit PAF53 or Pol I to rDNA, resulting in inhibition of pre-rRNA transcription.\",\n      \"method\": \"In vitro autoacetylation assay, site-directed mutagenesis (K426R), co-immunoprecipitation, ChIP, pre-rRNA measurement\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro assay, mutagenesis, ChIP, and Co-IP in a single study; establishes PAF53 recruitment downstream of UBF acetylation\",\n      \"pmids\": [\"27993683\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"PAF53 (mammalian orthologue of yeast Rpa49) is essential for rDNA transcription and mitotic cell growth in mammalian cells, as demonstrated by auxin-inducible degron depletion. All three PAF53 domains are required for function: the C-terminal tandem-winged helix (DNA-binding), the heterodimerization domain, and the linker domain. The linker contains a helix-turn-helix (HTH) motif that constitutes a second DNA-binding domain and is essential for function in both yeast and mammalian orthologues.\",\n      \"method\": \"CRISPR/Cas9 + auxin-inducible degron system, domain-deletion mutagenesis, rDNA transcription assays, cell growth assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional depletion with auxin degron plus systematic domain mutagenesis in mammalian cells with multiple functional readouts; conserved HTH domain validated in both yeast and mammalian orthologues\",\n      \"pmids\": [\"31727736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In yeast, extragenic suppressors of rpa49-Δ growth defect map to the jaw-lobe module of Pol I (interface between lobe of Rpa135 and jaw of Rpa190/Rpa12), and the suppressor allele Rpa135-F301S restores normal rRNA synthesis and increases Pol I density on rDNA in the absence of Rpa49. In vitro tailed-template assays show Pol I bearing Rpa135-F301S is hyperactive, indicating Rpa49 (PAF53 orthologue) normally acts through this jaw-lobe interface to stimulate Pol I elongation activity.\",\n      \"method\": \"Genetic suppressor screen, biochemical rRNA synthesis analysis, in vitro tailed-template transcription assay, ChIP (Pol I density)\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — genetic suppressor analysis combined with in vitro transcription assay and ChIP; establishes mechanistic connection between Rpa49/PAF53 and specific Pol I structural domains\",\n      \"pmids\": [\"31136569\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Pol I mutants lacking the heterodimeric subunit Rpa34.5/Rpa49 (PAF49/PAF53 orthologue) show reduced processivity on naked DNA templates and even further reduced processivity in the presence of a nucleosomal barrier. Purified wild-type Pol I and Pol III (but not Pol II) can transcribe nucleosomal templates; the lobe-binding subunits Rpa34.5/Rpa49 facilitate passage through nucleosomes, suggesting a role for the PAF49/PAF53 heterodimer in chromatin transcription.\",\n      \"method\": \"In vitro transcription assays with purified WT and mutant Pol I on naked DNA and nucleosomal templates; comparison with Pol II and Pol III\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with purified polymerases and defined templates including nucleosomal substrates; direct comparison of WT vs. subunit-deletion mutants\",\n      \"pmids\": [\"32060094\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"PAF53 is essential for mammalian cell survival. CRISPR/Cas9-mediated knockout of PAF53 in human 293 cells was only achieved when cells were simultaneously rescued with ectopic FLAG-tagged mouse PAF53. In the absence of ectopic expression, cells employed alternative survival mechanisms (recombination, alternative reading frames) to maintain PAF53 expression, and no clone lacking all PAF53 expression was obtained.\",\n      \"method\": \"CRISPR/Cas9 gene editing, DNA sequencing of modified loci, Western blot\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic essentiality demonstrated by inability to achieve full knockout without rescue, single lab\",\n      \"pmids\": [\"28042089\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"PAF49 is essential for rDNA transcription and cell division in mammalian cells. Auxin-induced degradation of PAF49 leads to degradation of its binding partner PAF53 (but not vice versa), demonstrating a co-dependent stability relationship. PAF49 depletion induces nucleolar stress and p53 accumulation. The dimerization domain of PAF49 and an 'arm' domain that interacts with PolR1B are both required for rDNA transcription. Disruption of the PAF49–PolR1B interaction inhibits Pol I transcription and causes cancer cell death while arresting normal cells.\",\n      \"method\": \"Auxin-inducible degron system, domain deletion mutagenesis, co-immunoprecipitation, rDNA transcription assays, cell viability assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional depletion, domain mutagenesis, Co-IP, and functional transcription assays with cancer vs. normal cell comparison; establishes PAF53 stability depends on PAF49 but not the reverse\",\n      \"pmids\": [\"37356716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In the yeast system, the N-terminal domains of the Rpa34.5/Rpa49 heterodimer (PAF49/PAF53 orthologue) facilitate backtracking and RNA cleavage activity of Pol I in defined in vitro systems. The heterodimer, together with the C-terminal domain of Rpa12.2, is required for transcription fidelity (faithful NTP incorporation), suggesting that efficient backtracking and RNA cleavage enabled by the heterodimer are prerequisites for proofreading.\",\n      \"method\": \"In vitro transcription assays with purified mutant Pol I variants, RNA cleavage assays, backtracking assays, fidelity assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro reconstitution with defined mutant polymerases and multiple functional assays (cleavage, backtracking, fidelity) in a single rigorous study\",\n      \"pmids\": [\"35341765\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"POLR1E (PAF53) is a constitutive, stoichiometric subunit of RNA polymerase I that forms an essential heterodimer with PAF49 (A34.5 orthologue); this heterodimer structurally resembles a TFIIF/TFIIE-like subcomplex and functions at multiple steps of the Pol I transcription cycle—facilitating initiation (through interaction with UBF and recruitment of Rrn3), promoting elongation and high polymerase loading rates on rDNA, enabling transcription through nucleosomal barriers, and supporting RNA cleavage and proofreading—while its activity is regulated by SIRT7-mediated deacetylation and CBP-mediated acetylation at lysine 373, with hypoacetylation promoting Pol I–rDNA association and hyperacetylation (triggered by stress-induced SIRT7 release from nucleoli) causing transcriptional repression.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"POLR1E (PAF53) is a constitutive, stoichiometric subunit of RNA polymerase I that is essential for accurate rDNA transcription and cell proliferation [#1, #14, #17]. It assembles into a heterodimer with PAF49 through PAF49's N-terminal segment (mammalian residues 41\\u201386), an interface conserved with the yeast Rpa34.5/Rpa49 module [#4, #11], and this co-dependent pair is mutually stabilizing such that loss of PAF49 triggers PAF53 degradation, nucleolar stress, and p53 accumulation [#18]. PAF53 functions across the Pol I transcription cycle: it interacts with the upstream binding factor UBF to enable accurate initiation [#0], and its recruitment to rDNA is driven by acetylation of UBF [#5]. Studies of the yeast orthologue establish that the heterodimer acts through the Pol I jaw-lobe interface to stimulate elongation and high polymerase loading rates, facilitates passage through nucleosomal barriers, and supports backtracking, RNA cleavage, and transcriptional fidelity [#15, #16, #19]; the protein's C-terminal tandem-winged-helix DNA-binding domain, heterodimerization domain, and an HTH-containing linker that forms a second DNA-binding module are all required for function [#14]. PAF53 activity is regulated by reversible acetylation at lysine 373, deacetylated by SIRT7 to promote Pol I\\u2013rDNA association and acetylated by CBP, with stress-induced release of SIRT7 from nucleoli causing hyperacetylation and transcriptional repression [#9].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established PAF53 as a Pol I factor physically engaging UBF and functionally required for promoter-specific initiation, distinguishing it from general transcription activity.\",\n      \"evidence\": \"GST pull-down, Far-Western, and antibody inhibition of in vitro rRNA-promoter transcription, with nucleolar immunofluorescence\",\n      \"pmids\": [\"8641287\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define which PAF53 domain contacts UBF\", \"Role beyond initiation (elongation, termination) untested\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Resolved whether PAF53 is a regulatory adaptor or a core enzyme component by showing a constant stoichiometric ratio to RPA116 across growth and repression states.\",\n      \"evidence\": \"Immunoblot, Co-IP, and immunofluorescence comparing purified Pol I fractions under serum starvation, actinomycin, and mitosis\",\n      \"pmids\": [\"9254723\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Constitutive association leaves open how transcriptional output is regulated\", \"No structural placement within Pol I\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Tracked the dynamics of PAF53/Pol I assembly during meiosis, showing stepwise Pol I disassembly distinct from UBF retention.\",\n      \"evidence\": \"High-resolution confocal immunofluorescence in mouse oocytes with okadaic acid treatment\",\n      \"pmids\": [\"10882521\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Descriptive localization without mechanism of disassembly\", \"Phosphorylation triggers inferred from inhibitor only\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Placed the PAF53 orthologue Rpa49 in a common essential Pol I pathway with the HMG-box protein Hmo1 through genetic epistasis.\",\n      \"evidence\": \"Suppressor analysis, double-mutant lethality, and rRNA synthesis in S. cerevisiae\",\n      \"pmids\": [\"12374750\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not define the biochemical step shared by Rpa49 and Hmo1\", \"Mammalian relevance of Hmo1 link untested\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Identified PAF49 as the direct heterodimer partner of PAF53 and confirmed both reside in the active Pol I fraction and are required for initiation.\",\n      \"evidence\": \"Reciprocal Co-IP, co-purification, and antibody inhibition/recombinant rescue of in vitro transcription\",\n      \"pmids\": [\"15226435\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Heterodimer interface not mapped\", \"Functional role of dimer beyond initiation unresolved\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined acetylation of UBF as a control point that strengthens the UBF\\u2013PAF53 interaction and drives Pol I recruitment to rDNA.\",\n      \"evidence\": \"Co-IP, ChIP, and inducible HDAC1 overexpression with pre-rRNA measurement\",\n      \"pmids\": [\"16582105\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Acetyltransferase responsible not identified here\", \"Direct vs. indirect effect on PAF53 not separated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Defined the dual mechanistic role of the Rpa49/Rpa34 (PAF53/PAF49) heterodimer in recruiting Rrn3 and in releasing Rrn3 from elongating polymerase.\",\n      \"evidence\": \"Two-hybrid, Co-IP, ChIP, and genetic mutant analysis in yeast\",\n      \"pmids\": [\"18086878\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mammalian conservation of Rrn3 handoff not directly shown here\", \"Structural basis of Rrn3 release unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified hALP as an acetyltransferase that acetylates UBF, promotes UBF\\u2013PAF53 association, and drives PAF53 nuclear translocation.\",\n      \"evidence\": \"Co-IP, GST pull-down, immunofluorescence, and HAT-dead mutant analysis\",\n      \"pmids\": [\"21177859\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab finding without independent confirmation\", \"Physiological context regulating PAF53 import unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Quantified the elongation contribution of the PAF53 orthologue, showing it is required for nucleolar structure and high polymerase loading, and that function is conserved across species.\",\n      \"evidence\": \"Genetic deletion, heterospecific complementation with human/S. pombe orthologues, and Miller-spread electron microscopy in yeast\",\n      \"pmids\": [\"21263028\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of loading-rate increase not resolved here\", \"Link to specific Pol I structural elements pending\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Mapped the heterodimerization interface to PAF49 residues 41\\u201386 and demonstrated its conservation via a functional yeast chimera.\",\n      \"evidence\": \"Deletion/substitution mutagenesis, Co-IP, and chimeric-protein heterodimerization assays\",\n      \"pmids\": [\"22849406\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Crystal structure of the interface not determined\", \"Consequences of interface disruption on transcription untested here\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Established lysine 373 acetylation as a regulatory switch on PAF53 controlled by SIRT7 and CBP, linking stress signaling to Pol I activity.\",\n      \"evidence\": \"In vitro deacetylation, K373 site-directed mutagenesis, ChIP, Co-IP, RNA-binding, and stress-condition experiments\",\n      \"pmids\": [\"24207024\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How K373 acetylation alters PAF53 contacts mechanistically unresolved\", \"Other PAF53 modification sites not surveyed\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Showed the PAF49/PAF53 heterodimer contacts Rrn3 in mammals and that PAF49 acetylation tunes heterodimer affinity for Pol I without disrupting dimerization.\",\n      \"evidence\": \"Co-IP, acetylation analysis, and affinity binding assays\",\n      \"pmids\": [\"25225125\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Acetyltransferase/deacetylase for PAF49 not identified\", \"In vivo significance of affinity change untested\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrated PAF53 is essential for mammalian cell survival, as knockout could not be obtained without ectopic rescue.\",\n      \"evidence\": \"CRISPR/Cas9 editing with locus sequencing and Western blot in 293 cells\",\n      \"pmids\": [\"28042089\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Essentiality shown by inability to knock out, not by clean conditional depletion\", \"Cause of lethality not dissected here\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Positioned PAF53 recruitment downstream of NAT10-mediated UBF acetylation, adding another acetyltransferase to the recruitment cascade.\",\n      \"evidence\": \"In vitro autoacetylation, NAT10 K426R mutagenesis, Co-IP, ChIP, and pre-rRNA measurement\",\n      \"pmids\": [\"27993683\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relationship between NAT10 and other UBF acetyltransferases (hALP) unresolved\", \"Direct PAF53 contact with NAT10 not shown\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined the domain architecture required for PAF53 function, including a second HTH DNA-binding module in the linker, using clean conditional depletion in mammalian cells.\",\n      \"evidence\": \"Auxin-inducible degron depletion plus systematic domain-deletion mutagenesis with rDNA transcription and growth assays\",\n      \"pmids\": [\"31727736\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise DNA target of the HTH module unknown\", \"How the two DNA-binding domains coordinate on rDNA unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Localized PAF53/Rpa49 elongation stimulation to the Pol I jaw-lobe interface through suppressor genetics and biochemistry.\",\n      \"evidence\": \"Suppressor screen, in vitro tailed-template transcription, and ChIP of Pol I density in yeast\",\n      \"pmids\": [\"31136569\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural snapshot of the active jaw-lobe conformation not captured\", \"Mammalian conservation of this allosteric route untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showed the heterodimer enables Pol I processivity through nucleosomal barriers, extending its role to chromatin transcription.\",\n      \"evidence\": \"In vitro transcription with purified WT and subunit-deletion Pol I on naked and nucleosomal templates, compared with Pol II/III\",\n      \"pmids\": [\"32060094\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of nucleosome destabilization by the heterodimer unresolved\", \"In vivo chromatin templates not directly tested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Assigned a proofreading function to the heterodimer by showing its N-terminal domains drive backtracking and RNA cleavage required for fidelity.\",\n      \"evidence\": \"In vitro transcription, RNA cleavage, backtracking, and fidelity assays with purified mutant Pol I\",\n      \"pmids\": [\"35341765\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Contribution of mammalian PAF53 to fidelity not directly tested\", \"Interplay with Rpa12.2 C-terminal domain only partly resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Established the co-dependent stability of the heterodimer (PAF49 loss degrades PAF53 but not vice versa) and identified the PAF49\\u2013PolR1B interaction as a druggable Pol I dependency in cancer cells.\",\n      \"evidence\": \"Auxin degron depletion, domain mutagenesis, Co-IP, and viability assays comparing cancer vs. normal cells\",\n      \"pmids\": [\"37356716\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the PAF49\\u2013PolR1B 'arm' interaction not defined\", \"Selectivity window for cancer-cell killing not mechanistically explained\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the multiple regulatory layers (K373 acetylation, UBF-acetylation-driven recruitment, jaw-lobe elongation control) are integrated in vivo, and whether mammalian PAF53 directly contributes to proofreading, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No integrated structural model of regulated PAF53 across the transcription cycle\", \"Direct mammalian assays for backtracking/fidelity lacking\", \"Disease association of POLR1E not established in the corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [14]},\n      {\"term_id\": \"GO:0140098\", \"supporting_discovery_ids\": [16, 19]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [1, 4]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 6, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [0, 1, 8]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 4, 14]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [16, 19]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [9, 18]}\n    ],\n    \"complexes\": [\n      \"RNA polymerase I\",\n      \"PAF53\\u2013PAF49 heterodimer\"\n    ],\n    \"partners\": [\n      \"PAF49\",\n      \"UBF\",\n      \"RRN3\",\n      \"SIRT7\",\n      \"CBP\",\n      \"POLR1B\",\n      \"RPA116\"\n    ],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}